Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes
Objective: Lifelong insulin replacement remains the mainstay of type 1 diabetes treatment. Genetic FoxO1 ablation promotes enteroendocrine cell (EECs) conversion into glucose-responsive β-like cells. Here, we tested whether chemical FoxO1 inhibitors can generate β-like gut cells. Methods: We used Ng...
Saved in:
Main Authors: | Takumi Kitamoto (Author), Yun-Kyoung Lee (Author), Nishat Sultana (Author), Hitoshi Watanabe (Author), Wendy M. McKimpson (Author), Wen Du (Author), Jason Fan (Author), Bryan Diaz (Author), Hua V. Lin (Author), Rudolph L. Leibel (Author), Sandro Belvedere (Author), Domenico Accili (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice
by: Yun-Kyoung Lee, et al.
Published: (2022) -
FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice
by: Yun-Kyoung Lee, et al.
Published: (2021) -
Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure
by: Jason Fan, et al.
Published: (2020) -
Role of FoxO1 in acne and effect of isotretinoin on FoxO1 expression
by: Parul Kamboj, et al.
Published: (2024) -
Antagonistic epistasis of Hnf4α and FoxO1 metabolic networks through enhancer interactions in β-cell function
by: Taiyi Kuo, et al.
Published: (2021)